New models of large-cell neuroendocrine carcinoma and small-cell lung carcinoma.
LCNEC
Lung cancer
Pten
Rb1
Rbl1
SCLC
Trp53
cell of origin
molecular imaging
tumor suppressors
Journal
Molecular & cellular oncology
ISSN: 2372-3556
Titre abrégé: Mol Cell Oncol
Pays: United States
ID NLM: 101642411
Informations de publication
Date de publication:
2020
2020
Historique:
received:
02
12
2019
revised:
04
12
2019
accepted:
05
12
2019
entrez:
12
3
2020
pubmed:
12
3
2020
medline:
12
3
2020
Statut:
epublish
Résumé
High-grade neuroendocrine lung carcinomas (LCNEC, SCLC) are recalcitrant cancers for which no optimal management has been achieved. We have recently described two models of LCNEC and SCLC developed upon inactivation of 4 tumor suppressors genes (
Identifiants
pubmed: 32158917
doi: 10.1080/23723556.2019.1702413
pii: 1702413
pmc: PMC7051149
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1702413Informations de copyright
© 2020 Taylor & Francis Group, LLC.
Références
Cancer Res. 2010 May 15;70(10):3877-83
pubmed: 20406986
Genes Dev. 2015 Jul 15;29(14):1447-62
pubmed: 26220992
Nat Rev Cancer. 2018 Sep;18(9):549-561
pubmed: 29849070
J Thorac Oncol. 2015 Apr;10(4):553-64
pubmed: 25675280
Proc Natl Acad Sci U S A. 2014 Apr 1;111(13):4952-7
pubmed: 24586047
Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):255-60
pubmed: 24367082
Nat Commun. 2018 Mar 13;9(1):1048
pubmed: 29535388
J Thorac Oncol. 2015 Sep;10(9):1243-1260
pubmed: 26291008
Cancer Cell. 2011 Jun 14;19(6):754-64
pubmed: 21665149
Proc Natl Acad Sci U S A. 2019 Oct 29;116(44):22300-22306
pubmed: 31611390